Investment
Features
FeesSafety
Academy
More
Pluang+

Gradient Investments boosts stake in DexCom by 13.8% amid positive earnings and analyst upgrades.

Market News
23 Mar 2026
Defense World
View Source
Bullish
pluang ai news

Gradient Investments LLC increased its holdings in DexCom, Inc. by 13.8% in Q4, owning 332,006 shares valued at $22 million. DexCom recently reported better-than-expected earnings with $0.68 EPS and $1.26 billion revenue, showing 13.1% growth year-over-year. Analysts have mostly positive outlooks, with several buy ratings and price targets up to $95. The company remains a leader in continuous glucose monitoring technology, with strong institutional ownership and ongoing insider activity.

More News (DXCM)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App